| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |